Search - tctmd.com

Displaying 221 - 240 of 637

Sort: Relevancy | Date

Presentation TCT 2016

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor

November 01, 2016

Presentation TCT 2016

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease

Presenter: Howard C. Herrmann, Robert J. de Winter, Giora Weisz

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

Presentation TCT 2016

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

Presenter: Robert M. Bersin, John R. Laird Jr., Piotr Musialek

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali

November 01, 2016

Presentation TCT 2016

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert

November 01, 2016

Presentation TCT 2016

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

Presenter: Michael J. Cowley, Franz-Josef Neumann, Joel Sainsous

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

A Prospective, Single-Center, Randomized Study to Assess Whether Co-Registration of OCT and Angiography can Reduce Geographic Miss

Presenter: Spencer B. King III, Jagat Narula, Kohei Koyama

October 31, 2016

Presentation TCT 2016

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen

October 31, 2016

Presentation TCT 2016

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone

October 31, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Presentation TCT 2016

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: David W.M. Muller, Jonathan M. Hill, Patrick W. Serruys

October 30, 2016

News Industry News

Study Examines Use of Optical Coherence Tomography Compared to Intravascular Ultrasound and Angiography to Guide Coronary Stent Implantation

October 30, 2016

Presentation TCT 2016

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, David E. Kandzari

October 30, 2016

Presentation TCT 2016

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen

October 30, 2016

Presentation TCT 2016

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Wayne B. Batchelor, Ziad A. Ali

October 30, 2016

News Daily News

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Shelley Wood

October 03, 2016

Advertisement

PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities

COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Twelve-Month Safety and Efficacy of CGuard Micro-Net-Covered Embolic Prevention System: Routine Use to Perform Carotid Revascularization in Symptomatic and Increased Stroke Risk Asymptomatic Patients: The PARADIGM All-Comer Prospective Study

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO

TCT 51: In-Hospital and One-Month Outcomes of 983 Patients Implanted With Bioresorbable Vascular Scaffolds for Acute Coronary Syndroms; Subgroup of the Prospective, All Comers, Controlled, Multicenter, FRANCE ABSORB Registry

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

A Prospective, Single-Center, Randomized Study to Assess Whether Co-Registration of OCT and Angiography can Reduce Geographic Miss

NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

ABSORB II: Three-Year Clinical Outcomes From a Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Vascular Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Study Examines Use of Optical Coherence Tomography Compared to Intravascular Ultrasound and Angiography to Guide Coronary Stent Implantation

BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease

BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease

ILUMIEN III (OPTIMIZE PCI): A Prospective, Randomized Trial of OCT-Guided vs IVUS-Guided vs Angio-Guided Stent Implantation in Patients With Coronary Artery Disease

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content